Anne O'Donnell Luria, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rare Diseases | 12 | 2024 | 622 | 3.360 |
Why?
|
Genetic Variation | 18 | 2024 | 6567 | 1.390 |
Why?
|
Genome, Human | 15 | 2024 | 4425 | 0.820 |
Why?
|
Genomics | 11 | 2023 | 5821 | 0.790 |
Why?
|
Inheritance Patterns | 1 | 2023 | 341 | 0.750 |
Why?
|
Phenotype | 31 | 2024 | 16591 | 0.740 |
Why?
|
Genetic Testing | 9 | 2024 | 3537 | 0.700 |
Why?
|
Heterozygote | 6 | 2024 | 2787 | 0.550 |
Why?
|
DNA Copy Number Variations | 3 | 2024 | 2020 | 0.550 |
Why?
|
Hyperammonemia | 1 | 2017 | 76 | 0.530 |
Why?
|
Genetic Association Studies | 9 | 2022 | 2735 | 0.520 |
Why?
|
Glutamine | 1 | 2017 | 577 | 0.450 |
Why?
|
Software | 6 | 2024 | 4434 | 0.440 |
Why?
|
Coma | 1 | 2017 | 484 | 0.430 |
Why?
|
Pathology, Molecular | 1 | 2016 | 328 | 0.420 |
Why?
|
Genetic Predisposition to Disease | 16 | 2024 | 17904 | 0.410 |
Why?
|
Databases, Genetic | 8 | 2023 | 1742 | 0.400 |
Why?
|
DNA Methylation | 7 | 2024 | 4398 | 0.400 |
Why?
|
Genome | 7 | 2023 | 1740 | 0.390 |
Why?
|
Computational Biology | 5 | 2024 | 3518 | 0.390 |
Why?
|
Sequence Analysis, DNA | 8 | 2024 | 4740 | 0.380 |
Why?
|
Haploinsufficiency | 4 | 2023 | 337 | 0.380 |
Why?
|
Penetrance | 4 | 2023 | 383 | 0.380 |
Why?
|
Arthrogryposis | 2 | 2022 | 68 | 0.360 |
Why?
|
Muscular Diseases | 3 | 2024 | 553 | 0.360 |
Why?
|
Muscular Dystrophies | 2 | 2023 | 390 | 0.330 |
Why?
|
Gene Frequency | 8 | 2024 | 3606 | 0.320 |
Why?
|
Mutation | 21 | 2024 | 30052 | 0.320 |
Why?
|
Cytosine | 1 | 2009 | 211 | 0.300 |
Why?
|
Microcephaly | 2 | 2023 | 425 | 0.290 |
Why?
|
Epilepsy | 2 | 2021 | 3290 | 0.280 |
Why?
|
Genetic Diseases, Inborn | 2 | 2024 | 604 | 0.280 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2017 | 3769 | 0.270 |
Why?
|
Genetics, Population | 2 | 2023 | 937 | 0.270 |
Why?
|
DNA-Binding Proteins | 3 | 2024 | 9606 | 0.270 |
Why?
|
Humans | 89 | 2024 | 761504 | 0.260 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2021 | 1651 | 0.250 |
Why?
|
Isotopes | 1 | 2004 | 125 | 0.240 |
Why?
|
alpha-Glucosidases | 1 | 2004 | 45 | 0.240 |
Why?
|
Disease | 2 | 2020 | 672 | 0.240 |
Why?
|
Consanguinity | 2 | 2017 | 456 | 0.240 |
Why?
|
Craniofacial Abnormalities | 2 | 2024 | 319 | 0.230 |
Why?
|
RNA, Small Nuclear | 1 | 2024 | 75 | 0.230 |
Why?
|
De Lange Syndrome | 1 | 2024 | 21 | 0.230 |
Why?
|
Mammals | 1 | 2009 | 1132 | 0.220 |
Why?
|
Turner Syndrome | 1 | 2015 | 129 | 0.220 |
Why?
|
Solvents | 1 | 2004 | 295 | 0.220 |
Why?
|
Mutation, Missense | 5 | 2024 | 2571 | 0.220 |
Why?
|
Genetic Counseling | 2 | 2021 | 627 | 0.220 |
Why?
|
Developmental Disabilities | 4 | 2023 | 1509 | 0.220 |
Why?
|
Pedigree | 6 | 2021 | 4542 | 0.220 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2024 | 535 | 0.200 |
Why?
|
Exons | 3 | 2023 | 2391 | 0.200 |
Why?
|
Nanopores | 1 | 2022 | 44 | 0.200 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2024 | 3639 | 0.200 |
Why?
|
Vestibular Diseases | 1 | 2024 | 230 | 0.190 |
Why?
|
Zebrafish | 2 | 2024 | 3007 | 0.190 |
Why?
|
Intranuclear Space | 1 | 2021 | 15 | 0.190 |
Why?
|
Neuromuscular Diseases | 1 | 2024 | 258 | 0.190 |
Why?
|
Homozygote | 4 | 2021 | 1776 | 0.190 |
Why?
|
Face | 2 | 2024 | 1026 | 0.180 |
Why?
|
Repressor Proteins | 3 | 2020 | 2986 | 0.180 |
Why?
|
Primates | 1 | 2023 | 523 | 0.180 |
Why?
|
Hematologic Diseases | 1 | 2024 | 496 | 0.180 |
Why?
|
Selection, Genetic | 3 | 2023 | 868 | 0.170 |
Why?
|
Brain | 10 | 2024 | 27112 | 0.170 |
Why?
|
Calibration | 1 | 2022 | 818 | 0.170 |
Why?
|
Chloride Channels | 1 | 2021 | 221 | 0.170 |
Why?
|
Uniparental Disomy | 1 | 2019 | 45 | 0.170 |
Why?
|
Ophthalmoplegia | 1 | 2021 | 168 | 0.170 |
Why?
|
Abnormalities, Multiple | 2 | 2024 | 1423 | 0.170 |
Why?
|
Chromosome Deletion | 1 | 2024 | 1386 | 0.170 |
Why?
|
CpG Islands | 4 | 2020 | 1230 | 0.170 |
Why?
|
Histone Acetyltransferases | 1 | 2021 | 336 | 0.170 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2022 | 267 | 0.160 |
Why?
|
Child | 18 | 2024 | 80153 | 0.160 |
Why?
|
Chromosome Mapping | 4 | 2023 | 4615 | 0.160 |
Why?
|
Adenosine Deaminase | 1 | 2021 | 251 | 0.160 |
Why?
|
Movement Disorders | 1 | 2023 | 459 | 0.160 |
Why?
|
Genes, Essential | 1 | 2020 | 185 | 0.160 |
Why?
|
Malformations of Cortical Development | 1 | 2021 | 176 | 0.160 |
Why?
|
5' Untranslated Regions | 1 | 2020 | 256 | 0.160 |
Why?
|
Infertility, Female | 1 | 2015 | 760 | 0.160 |
Why?
|
Hydroxocobalamin | 1 | 2018 | 27 | 0.160 |
Why?
|
Anemia, Megaloblastic | 1 | 2018 | 24 | 0.160 |
Why?
|
Spasms, Infantile | 1 | 2022 | 298 | 0.160 |
Why?
|
Cohort Studies | 9 | 2024 | 41487 | 0.160 |
Why?
|
Uncertainty | 1 | 2023 | 754 | 0.150 |
Why?
|
Child, Preschool | 13 | 2024 | 42230 | 0.150 |
Why?
|
Membrane Glycoproteins | 2 | 2020 | 3702 | 0.150 |
Why?
|
Eczema | 1 | 2020 | 246 | 0.150 |
Why?
|
Physicians | 1 | 2016 | 4591 | 0.150 |
Why?
|
Molecular Sequence Annotation | 1 | 2020 | 522 | 0.150 |
Why?
|
Anemia, Diamond-Blackfan | 1 | 2018 | 138 | 0.150 |
Why?
|
Abortion, Spontaneous | 1 | 2023 | 533 | 0.150 |
Why?
|
Multifactorial Inheritance | 2 | 2023 | 1387 | 0.150 |
Why?
|
Niemann-Pick Disease, Type C | 1 | 2017 | 49 | 0.140 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2021 | 335 | 0.140 |
Why?
|
Sodium Benzoate | 1 | 2017 | 14 | 0.140 |
Why?
|
Genetics, Medical | 1 | 2020 | 334 | 0.140 |
Why?
|
Xenopus Proteins | 1 | 2020 | 434 | 0.140 |
Why?
|
Tubulin | 1 | 2021 | 693 | 0.140 |
Why?
|
Marfan Syndrome | 1 | 2019 | 236 | 0.140 |
Why?
|
Neuropeptides | 1 | 2023 | 944 | 0.140 |
Why?
|
Phenylacetates | 1 | 2017 | 112 | 0.140 |
Why?
|
Male | 35 | 2024 | 360804 | 0.140 |
Why?
|
Cerebral Palsy | 1 | 2022 | 474 | 0.140 |
Why?
|
Genome-Wide Association Study | 6 | 2024 | 12690 | 0.140 |
Why?
|
Thrombotic Microangiopathies | 1 | 2018 | 123 | 0.140 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2024 | 682 | 0.140 |
Why?
|
Nephrotic Syndrome | 1 | 2021 | 390 | 0.140 |
Why?
|
DNA Mutational Analysis | 4 | 2020 | 4111 | 0.140 |
Why?
|
Female | 33 | 2024 | 392644 | 0.140 |
Why?
|
Embryo, Nonmammalian | 1 | 2020 | 906 | 0.140 |
Why?
|
Multigene Family | 1 | 2019 | 1076 | 0.130 |
Why?
|
Ion Channels | 1 | 2021 | 1040 | 0.130 |
Why?
|
Adolescent | 14 | 2024 | 88319 | 0.130 |
Why?
|
Carrier Proteins | 2 | 2021 | 4936 | 0.130 |
Why?
|
Histone Deacetylases | 1 | 2020 | 719 | 0.130 |
Why?
|
Gene Deletion | 3 | 2019 | 2665 | 0.130 |
Why?
|
Glutamates | 1 | 2017 | 389 | 0.130 |
Why?
|
Models, Genetic | 2 | 2023 | 3442 | 0.130 |
Why?
|
Body Patterning | 1 | 2020 | 632 | 0.130 |
Why?
|
Growth Disorders | 1 | 2020 | 655 | 0.130 |
Why?
|
Genetic Heterogeneity | 1 | 2019 | 732 | 0.120 |
Why?
|
Alleles | 6 | 2024 | 6863 | 0.120 |
Why?
|
Protein Biosynthesis | 1 | 2022 | 2113 | 0.120 |
Why?
|
Facies | 3 | 2021 | 222 | 0.120 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2020 | 842 | 0.120 |
Why?
|
Prion Diseases | 1 | 2016 | 100 | 0.120 |
Why?
|
Genotype | 7 | 2023 | 12990 | 0.110 |
Why?
|
Cardiomyopathies | 2 | 2024 | 1964 | 0.110 |
Why?
|
Fibrosis | 1 | 2021 | 2049 | 0.110 |
Why?
|
Autistic Disorder | 1 | 2023 | 1220 | 0.110 |
Why?
|
Dyslipidemias | 1 | 2021 | 868 | 0.110 |
Why?
|
Hematopoiesis | 1 | 2023 | 2049 | 0.110 |
Why?
|
Heart Defects, Congenital | 3 | 2024 | 4671 | 0.110 |
Why?
|
Thrombocytopenia | 1 | 2021 | 1181 | 0.110 |
Why?
|
Genes | 1 | 2017 | 1823 | 0.110 |
Why?
|
Histones | 2 | 2022 | 2580 | 0.110 |
Why?
|
Information Storage and Retrieval | 1 | 2018 | 819 | 0.110 |
Why?
|
Health | 1 | 2016 | 398 | 0.100 |
Why?
|
Infant | 8 | 2024 | 36192 | 0.100 |
Why?
|
Craniosynostoses | 1 | 2017 | 412 | 0.100 |
Why?
|
Syndrome | 3 | 2024 | 3267 | 0.100 |
Why?
|
Nerve Tissue Proteins | 2 | 2023 | 4414 | 0.100 |
Why?
|
Failure to Thrive | 2 | 2024 | 140 | 0.090 |
Why?
|
Young Adult | 6 | 2024 | 59243 | 0.090 |
Why?
|
Databases, Nucleic Acid | 1 | 2011 | 205 | 0.090 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2898 | 0.090 |
Why?
|
Amino Acid Substitution | 3 | 2020 | 1738 | 0.090 |
Why?
|
Spermatozoa | 1 | 2014 | 630 | 0.090 |
Why?
|
RNA Splice Sites | 2 | 2024 | 211 | 0.090 |
Why?
|
Base Sequence | 3 | 2023 | 12441 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2024 | 15936 | 0.080 |
Why?
|
Internet | 1 | 2022 | 3092 | 0.080 |
Why?
|
Psychiatry | 1 | 2022 | 1693 | 0.080 |
Why?
|
Virulence | 2 | 2024 | 1303 | 0.080 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 1858 | 0.080 |
Why?
|
Gastric Bypass | 1 | 2017 | 818 | 0.080 |
Why?
|
Adult | 12 | 2024 | 221177 | 0.080 |
Why?
|
HEK293 Cells | 3 | 2023 | 4278 | 0.080 |
Why?
|
Access to Information | 2 | 2023 | 316 | 0.080 |
Why?
|
Muscle, Skeletal | 4 | 2024 | 4948 | 0.070 |
Why?
|
Open Reading Frames | 2 | 2022 | 815 | 0.070 |
Why?
|
Mood Disorders | 1 | 2014 | 1127 | 0.070 |
Why?
|
Animals | 16 | 2024 | 168459 | 0.070 |
Why?
|
Methyltransferases | 1 | 2009 | 377 | 0.070 |
Why?
|
Patient Selection | 1 | 2018 | 4244 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7594 | 0.070 |
Why?
|
Nucleosomes | 1 | 2009 | 487 | 0.060 |
Why?
|
Pakistan | 2 | 2017 | 292 | 0.060 |
Why?
|
Evolution, Molecular | 2 | 2011 | 1886 | 0.060 |
Why?
|
Methylglucosides | 1 | 2004 | 35 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 6032 | 0.060 |
Why?
|
Deuterium Oxide | 1 | 2004 | 34 | 0.060 |
Why?
|
Buffers | 1 | 2004 | 146 | 0.060 |
Why?
|
Chromatin | 2 | 2022 | 2960 | 0.060 |
Why?
|
Amino Acid Sequence | 3 | 2021 | 13446 | 0.060 |
Why?
|
Enzyme Stability | 1 | 2004 | 219 | 0.060 |
Why?
|
Hypertrichosis | 1 | 2024 | 31 | 0.060 |
Why?
|
Gene Expression Regulation | 1 | 2022 | 11903 | 0.060 |
Why?
|
Spliceosomes | 1 | 2024 | 130 | 0.060 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2024 | 141 | 0.060 |
Why?
|
National Human Genome Research Institute (U.S.) | 1 | 2023 | 22 | 0.060 |
Why?
|
Sequence Analysis, RNA | 2 | 2024 | 2020 | 0.060 |
Why?
|
Hydrolysis | 1 | 2004 | 664 | 0.050 |
Why?
|
Suicide | 1 | 2014 | 1601 | 0.050 |
Why?
|
Dystroglycans | 1 | 2023 | 62 | 0.050 |
Why?
|
Dystrophin-Associated Proteins | 1 | 2023 | 59 | 0.050 |
Why?
|
Actinin | 1 | 2024 | 163 | 0.050 |
Why?
|
Karyotyping | 1 | 2015 | 1171 | 0.050 |
Why?
|
Cell Line | 3 | 2021 | 15601 | 0.050 |
Why?
|
Informatics | 1 | 2023 | 72 | 0.050 |
Why?
|
Transcription Factors | 3 | 2023 | 12128 | 0.050 |
Why?
|
Mental Disorders | 1 | 2022 | 6845 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18252 | 0.050 |
Why?
|
Blepharophimosis | 1 | 2021 | 21 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2022 | 12795 | 0.050 |
Why?
|
Connexins | 1 | 2023 | 352 | 0.050 |
Why?
|
Dystrophin | 1 | 2023 | 283 | 0.050 |
Why?
|
Congenital Hypothyroidism | 1 | 2021 | 40 | 0.050 |
Why?
|
Mice | 8 | 2023 | 81525 | 0.050 |
Why?
|
Disease Progression | 1 | 2018 | 13506 | 0.050 |
Why?
|
S Phase | 1 | 2002 | 421 | 0.050 |
Why?
|
Genes, Recessive | 1 | 2024 | 623 | 0.050 |
Why?
|
Glucosyltransferases | 1 | 2021 | 96 | 0.050 |
Why?
|
Scrotum | 1 | 2021 | 116 | 0.050 |
Why?
|
Chromosome Breakage | 1 | 2021 | 159 | 0.050 |
Why?
|
Psychomotor Disorders | 1 | 2021 | 149 | 0.050 |
Why?
|
Substrate Specificity | 1 | 2004 | 1791 | 0.040 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2020 | 44 | 0.040 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2015 | 497 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2023 | 2872 | 0.040 |
Why?
|
Radiation Tolerance | 1 | 2002 | 479 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2004 | 2496 | 0.040 |
Why?
|
Myoblasts | 1 | 2021 | 231 | 0.040 |
Why?
|
User-Computer Interface | 2 | 2019 | 1400 | 0.040 |
Why?
|
Patella | 1 | 2021 | 315 | 0.040 |
Why?
|
Middle Aged | 9 | 2024 | 220895 | 0.040 |
Why?
|
Genetic Loci | 2 | 2021 | 2632 | 0.040 |
Why?
|
Codon, Nonsense | 1 | 2021 | 285 | 0.040 |
Why?
|
Protons | 1 | 2004 | 1116 | 0.040 |
Why?
|
Siblings | 1 | 2023 | 825 | 0.040 |
Why?
|
Glycine | 1 | 2022 | 663 | 0.040 |
Why?
|
Pregnancy Trimester, First | 1 | 2023 | 907 | 0.040 |
Why?
|
Autopsy | 1 | 2023 | 1008 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2020 | 504 | 0.040 |
Why?
|
Psychopathology | 1 | 2022 | 432 | 0.040 |
Why?
|
Arginine | 1 | 2022 | 934 | 0.040 |
Why?
|
Immune System Diseases | 1 | 2021 | 256 | 0.040 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2024 | 727 | 0.040 |
Why?
|
Aging | 2 | 2014 | 8708 | 0.040 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2022 | 790 | 0.040 |
Why?
|
Urogenital Abnormalities | 1 | 2021 | 261 | 0.040 |
Why?
|
Chromosome Disorders | 1 | 2021 | 497 | 0.040 |
Why?
|
Filipin | 1 | 2017 | 13 | 0.040 |
Why?
|
Australia | 1 | 2021 | 1250 | 0.040 |
Why?
|
Temperature | 1 | 2004 | 2226 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2023 | 1093 | 0.040 |
Why?
|
Genomic Imprinting | 1 | 2019 | 329 | 0.040 |
Why?
|
Neuregulins | 1 | 2017 | 36 | 0.040 |
Why?
|
Collagen Type VI | 1 | 2017 | 25 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2018 | 239 | 0.040 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2018 | 118 | 0.040 |
Why?
|
Hydrops Fetalis | 1 | 2017 | 113 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 12148 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2018 | 554 | 0.030 |
Why?
|
Kinetics | 1 | 2004 | 6374 | 0.030 |
Why?
|
Binding Sites | 2 | 2021 | 6055 | 0.030 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2017 | 127 | 0.030 |
Why?
|
Podocytes | 1 | 2021 | 405 | 0.030 |
Why?
|
Reference Standards | 1 | 2020 | 1003 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2018 | 437 | 0.030 |
Why?
|
Ribosomal Proteins | 1 | 2018 | 371 | 0.030 |
Why?
|
Receptors, Notch | 1 | 2021 | 743 | 0.030 |
Why?
|
Muscles | 1 | 2021 | 1576 | 0.030 |
Why?
|
Germ Cells | 1 | 2020 | 634 | 0.030 |
Why?
|
Xenopus laevis | 1 | 2020 | 963 | 0.030 |
Why?
|
Aneuploidy | 1 | 2019 | 551 | 0.030 |
Why?
|
Liver Failure, Acute | 1 | 2017 | 181 | 0.030 |
Why?
|
BRCA1 Protein | 1 | 2002 | 1155 | 0.030 |
Why?
|
Kidney | 2 | 2021 | 7048 | 0.030 |
Why?
|
Genes, Lethal | 1 | 2016 | 223 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9420 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2023 | 1265 | 0.030 |
Why?
|
Apolipoprotein C-III | 1 | 2017 | 211 | 0.030 |
Why?
|
Ribosomes | 1 | 2018 | 501 | 0.030 |
Why?
|
Cell Cycle Proteins | 2 | 2024 | 3448 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 1 | 2023 | 1755 | 0.030 |
Why?
|
Postprandial Period | 1 | 2017 | 315 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2019 | 793 | 0.030 |
Why?
|
Educational Status | 1 | 2022 | 2522 | 0.030 |
Why?
|
HeLa Cells | 1 | 2021 | 3093 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2004 | 6534 | 0.030 |
Why?
|
Gene Dosage | 1 | 2019 | 1217 | 0.030 |
Why?
|
Haplotypes | 1 | 2021 | 2713 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1834 | 0.030 |
Why?
|
Prions | 1 | 2016 | 180 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 3712 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2017 | 695 | 0.030 |
Why?
|
Joint Instability | 1 | 2021 | 801 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2021 | 14414 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2004 | 2688 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2023 | 2057 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2018 | 64680 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2014 | 371 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2018 | 1186 | 0.030 |
Why?
|
Sample Size | 1 | 2016 | 841 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2024 | 3612 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 802 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3123 | 0.030 |
Why?
|
Glucose | 1 | 2004 | 4346 | 0.030 |
Why?
|
Neoplasm Proteins | 1 | 2024 | 3617 | 0.020 |
Why?
|
Prevalence | 2 | 2019 | 15732 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20098 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2021 | 1712 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 2021 | 1699 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2018 | 1298 | 0.020 |
Why?
|
Fathers | 1 | 2014 | 376 | 0.020 |
Why?
|
Pregnancy | 2 | 2023 | 29874 | 0.020 |
Why?
|
Fertility | 1 | 2016 | 771 | 0.020 |
Why?
|
Models, Molecular | 1 | 2021 | 5439 | 0.020 |
Why?
|
Fasting | 1 | 2017 | 1603 | 0.020 |
Why?
|
Information Dissemination | 1 | 2018 | 1126 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2010 | 162 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2019 | 6075 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2021 | 26198 | 0.020 |
Why?
|
Triglycerides | 1 | 2017 | 2461 | 0.020 |
Why?
|
Dietary Fats | 1 | 2017 | 1995 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2017 | 2330 | 0.020 |
Why?
|
Algorithms | 2 | 2021 | 14031 | 0.020 |
Why?
|
Seizures | 1 | 2021 | 2957 | 0.020 |
Why?
|
Risk Assessment | 2 | 2021 | 23995 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7212 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2017 | 2448 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3250 | 0.020 |
Why?
|
Pan troglodytes | 1 | 2007 | 223 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1670 | 0.020 |
Why?
|
Proteome | 1 | 2016 | 1862 | 0.020 |
Why?
|
Epigenesis, Genetic | 2 | 2011 | 3802 | 0.020 |
Why?
|
Epigenomics | 1 | 2011 | 943 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5336 | 0.020 |
Why?
|
Mothers | 1 | 2016 | 2198 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 16981 | 0.010 |
Why?
|
Cognition | 1 | 2022 | 6990 | 0.010 |
Why?
|
Motor Activity | 1 | 2014 | 2715 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2021 | 7856 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2007 | 1163 | 0.010 |
Why?
|
United States | 2 | 2023 | 72334 | 0.010 |
Why?
|
Risk Factors | 2 | 2023 | 74206 | 0.010 |
Why?
|
Species Specificity | 1 | 2007 | 2414 | 0.010 |
Why?
|
Coronary Disease | 1 | 2017 | 5914 | 0.010 |
Why?
|
G2 Phase | 1 | 2002 | 136 | 0.010 |
Why?
|
Liver | 1 | 2017 | 7529 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7581 | 0.010 |
Why?
|
Breast | 1 | 2010 | 1967 | 0.010 |
Why?
|
Aged | 3 | 2021 | 169289 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15842 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3792 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2007 | 1263 | 0.010 |
Why?
|
Genes, BRCA1 | 1 | 2002 | 764 | 0.010 |
Why?
|
Serine | 1 | 2002 | 830 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2016 | 22176 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23445 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29625 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18395 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11460 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 6132 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 80636 | 0.010 |
Why?
|
Transfection | 1 | 2002 | 5774 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15500 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36426 | 0.010 |
Why?
|
DNA Damage | 1 | 2002 | 2446 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2002 | 2803 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2017 | 58976 | 0.010 |
Why?
|
Phosphorylation | 1 | 2002 | 8320 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2002 | 21012 | 0.000 |
Why?
|